Skip to main content

Journal article Published 2023

Pro-905, a Novel Purine Antimetabolite, Combines with Glutamine Amidotransferase Inhibition to Suppress Growth of Malignant Peripheral Nerve Sheath Tumor

Authors

K.M. Lemberg, E.S. Ali, M. Krecmerova, J.M.H. Aguliar, J. Alt, D.E. Peters, L. Zhao, Y. Wu, N. Nuha, J.M. Asara, V. Staedtke, Ch.A. Pratilas, P. Majer, R. Rais, I. Ben-Sahra

Molecular Cancer Therapeutics 22(12), 1390-1403 (2023)

Cite this publication

LEMBERG, K., E. ALI, M. KRECMEROVA, J. AGULIAR, J. ALT, D. PETERS, L. ZHAO, Y. WU, N. NUHA, J. ASARA, V. STAEDTKE, C. PRATILAS, P. MAJER, R. RAIS, I. BEN-SAHRA: Pro-905, a Novel Purine Antimetabolite, Combines with Glutamine Amidotransferase Inhibition to Suppress Growth of Malignant Peripheral Nerve Sheath Tumor. Molecular Cancer Therapeutics. 2023, 22(12), 1390-1403, ISSN: 1535-7163, PMID: 37616542.

Details

ISSN
1535-7163